603351 logo

Nanjing Well Pharmaceutical Group Co.,Ltd. Stock Price

SHSE:603351 Community·CN¥3.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603351 Share Price Performance

CN¥26.90
2.64 (10.88%)
CN¥26.90
2.64 (10.88%)
Price CN¥26.90

603351 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with acceptable track record.

0 Risks
2 Rewards

Nanjing Well Pharmaceutical Group Co.,Ltd. Key Details

CN¥1.3b

Revenue

CN¥925.7m

Cost of Revenue

CN¥388.9m

Gross Profit

CN¥241.3m

Other Expenses

CN¥147.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
1.09
29.58%
11.23%
33.5%
View Full Analysis

About 603351

Founded
2000
Employees
711
CEO
Renrong Wu
WebsiteView website
www.well-js.com

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils to the pharmaceutical companies in China. It is involved in the bio-based material manufacturing, sales, and technology development; technical development and consulting; bio-based material technology research and development; biochemical product technology research and development; food and food additive production and sales; and research and development of new material technologies, as well as provides technical services; and manufactures and sells electronic materials. The company also exports its products to Europe, the United States, Southeast Asia, and internationally. The company was formerly known as Nanjing Well Pharmaceutical Co.,Ltd. and changed its name to Nanjing Well Pharmaceutical Group Co.,Ltd. in April 2020. Nanjing Well Pharmaceutical Group Co.,Ltd. was founded in 2000 and is based in Nanjing, China.

Recent 603351 News & Updates

Recent updates

No updates